Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Elite Pharmaceuticals Inc ELTP

Healthcare
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug... see more

Recent & Breaking News (OTCQB:ELTP)

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014

Globe Newswire November 14, 2013

Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013

Globe Newswire November 14, 2013

Elite Pharmaceuticals Announces Bridge Loan Facility

Globe Newswire October 16, 2013

Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products

Globe Newswire October 8, 2013

BlackBerry May be Going Private on Potential Fairfax Deal

Accesswire September 24, 2013

Shutterstock Zooms to a new 52-week High after Pricing Secondary Offering

Accesswire September 23, 2013

InvestorsGuru.com 41 Filtered Mid-Day Market Movers Recap

Investors Guru September 22, 2013

Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride

Globe Newswire September 18, 2013

Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

Globe Newswire September 3, 2013

Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013

Globe Newswire August 13, 2013

Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations

Globe Newswire August 12, 2013

Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer

Globe Newswire August 5, 2013

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History

Globe Newswire June 21, 2013

Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013

Globe Newswire June 19, 2013

Elite Laboratories Files Citizen Petition With the FDA on Brompheniramine Maleate and Pseudoephedrine HCL Extended Release

Globe Newswire June 10, 2013

Elite Pharmaceuticals Announces Change in Executive Leadership

Globe Newswire May 21, 2013

Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation

Globe Newswire April 23, 2013

Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC

Globe Newswire April 22, 2013

Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Phentermine Capsules

Globe Newswire April 11, 2013

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2013

Troy Schwensen February 14, 2013